No Data
Rubius Therapeutics To Go Ex-Dividend On January 2nd, 2024 With 0.05794 USD Dividend Per Share
Rubius Therapeutics (NASDAQ:RUBY) and Vigil Neuroscience (NASDAQ:VIGL) Critical Survey
Head to Head Analysis: Rubius Therapeutics (NASDAQ:RUBY) Versus Vigil Neuroscience (NASDAQ:VIGL)
National Bank Presents List of ETFs to Help Investors Monitor Market Situation
Rubius Therapeutics, Inc. (NASDAQ:RUBY) Sees Large Increase in Short Interest
Cardiol Therapeutics (NASDAQ:CRDL) & Rubius Therapeutics (NASDAQ:RUBY) Critical Survey
No Data
No Data
102315683 : Suspended 了
Shaul Heymans : delist already...yesterday just no choice but cut away
102765799 : can't be traded on moomoo. gosh
RIPPER : It’s gonna go to .11 or even .13 eventually